Innovation In Science

Argonne’s AI agents push materials R&D toward days-long cycles

Argonne’s new agentic workflows suggest a procurement shift: buy for dataflow and security, not bigger models.

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences initiates what it calls the first Phase I trial of an AI-designed oral drug formulation, approved by the UK's MHRA.

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I study of an AI-designed oral formulation, cleared by the MHRA, marking a concrete shift from AI experimentation to clin

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex didn’t just exhibit—it staged an experience that reflected the evolving intersection of materials science and brand storytelling. The company’s modern booth, complete with a living wall and immersive digital displays, signaled a broader shift in how packaging innovators are choosing to engage a sustainability-conscious audience. Beneath the…

Oscar Martin Interview – AMI Single Serve Tampa – 2026

The single-serve coffee industry is at a pivotal moment, where convenience and sustainability are no longer competing priorities but parallel expectations shaping innovation. At gatherings like the AMI Single Serve Coffee Conference in Tampa, the conversation has clearly shifted from abstract goals to tangible, commercially viable solutions—especially in the realm of compostable and recyclable…

Why Does Benchmark’s Work Need More Visibility

In an industry defined by rapid scientific breakthroughs, Benchmark Products plays a quietly pivotal role—translating innovation into tangible tools that life sciences manufacturers can actually use. By staying aligned with the evolving needs of patients and producers alike, Benchmark has built a reputation for agility, rapidly manufacturing solutions that improve efficiency and enable new…

AI-Driven Amino Acid Drugs Surface as a Promising Treatment for Eye Conditions

The rapid evolution of artificial intelligence (AI) promises to revolutionize multiple sectors, and one area seeing tangible benefits is drug development. Historically, the creation of new medicines was a time-consuming endeavor, but AI-driven amino acid research is proving to accelerate the early developmental stages and get drugs to the market faster. Researchers at the Wilmer…

Material Signs: Introduction to the World of Optics

Doctors Scott Carney, chief science and technology officer at Optica, Kate Medicus, CEO at Ruda-Cardinal, and Alexis Vogt, endowed chair and professor of optics at Monroe Community College, joined Host Tyler Kern for the very first podcast of Enpro’s Material Signs to talk about the world of optics and its impact on the world. Optics,…

Leaders Driving Change at SXSW: Part Two

The films and music that debut at SXSW every year may be what people remember, but alongside that star power stands innovation that changes the world. There will be no red carpet or paparazzi for the developers of these new products, but surely people around the world will feel their impact for years to…